Clinical Trial Update: Resmiterom Efficacy & Safety in Patients With MASH [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update indicating that Resmiterom is being studied for efficacy and safety in metabolic dysfunction-associated steatohepatitis (MASH) a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis

Drugs mentioned

• Resmiterom

Snippet

Sponsor: Nabiqasim Industries (Pvt) Ltd | Conditions: MASH - Metabolic Dysfunction-Associated Steatohepatitis | Phase 4 | Status: RECRUITING